Streamline Health Solutions, Inc. (STRM)
NASDAQ: STRM · Real-Time Price · USD
3.390
+0.240 (7.62%)
At close: Dec 20, 2024, 4:00 PM
3.220
-0.170 (-5.01%)
After-hours: Dec 20, 2024, 4:42 PM EST
STRM Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for STRM.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for STRM.
Recommendation Trends
Rating | Jul '22 | Aug '22 | Sep '22 | Oct '22 | Nov '22 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Lake Street | Lake Street | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +1,227.43% | Nov 21, 2022 |
Lake Street | Lake Street | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +1,227.43% | May 20, 2022 |
Lake Street | Lake Street | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 25, 2016 |
Lake Street | Lake Street | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | +4,324.78% | Feb 4, 2014 |
Financial Forecast
Revenue This Year
20.41M
from 22.60M
Decreased by -9.66%
Revenue Next Year
21.24M
from 20.41M
Increased by 4.04%
EPS This Year
-0.13
from -4.96
EPS Next Year
-0.11
from -0.13
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 21.0M | 21.9M |
Avg | 20.4M | 21.2M |
Low | 19.6M | 20.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | -7.0% | 7.1% |
Avg | -9.7% | 4.0% |
Low | -13.2% | -0.0% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.14 | -0.12 |
Avg | -0.13 | -0.11 |
Low | -0.13 | -0.11 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.